USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences
Foster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/ …